Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Eylea
Related studies linked through entity extraction aliases.
Ozurdex in Suboptimal Diabetic Macular Edema Patients
- Status
- UNKNOWN
- Phase
- NA
Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD
- Status
- COMPLETED
- Phase
- PHASE1
One Year Trial Evaluating Safety of Ozurdex With Eylea
- Status
- COMPLETED
- Phase
- PHASE4
Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE2
Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE3
ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
- Status
- WITHDRAWN
- Phase
- PHASE2
Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD
- Status
- COMPLETED
- Phase
- PHASE2
Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)
- Status
- COMPLETED
- Phase
- PHASE4